NCT01327365

Brief Summary

Background: The transradial approach is increasingly used in percutaneous coronary intervention (PCI) because of lower major access site complications, lower bleeding risk and earlier patient mobilization. According to this trend, in the last couple of years at the University Hospital of Geneva the investigators have changed their practice and currently the transradial approach is the most frequently used for PCI. However, the small diameter of the radial artery remains a major limitation of the technique, especially in women or for complex PCI necessitating larger bore guiding catheters. This may be overcome with sheathless guiding catheters (Asahi, Japan), allowing for a standard inner catheter diameter (6-7 Fr), with an outer diameter equivalent to a standard 5 and 6 Fr introducer sheath. Aim: This study is aimed to compare the transradial approach for PCI with a sheathless guiding catheter and with a standard guiding catheter in women and patients with complex lesion necessitating large bore guiding catheters. Material and methods: This prospective study will consecutively randomize all women and all men with bifurcation/ostial lesion of a major coronary vessel (i.e. ≈ 120/year) in whom a transradial PCI is attempted. The procedures will be performed either with a standard 6 or 7Fr guiding catheter or with the sheathless 6.5, 7.5 Fr catheters. End-points: Successful performance a transradial PCI in all consecutive patients which qualify according to the inclusion criteria (technical feasibility). Establish the proportion of procedures performed with no device-related complications (safety). Analyze in details the technical aspects of the sheathless catheter (efficacy). Sample size: The investigators have planed to include in the study ≈ 250 patients in two years. After 1 year of enrollment the investigators will perform an interim analysis and the instigators will decide at that moment, according to the observed end-points, if prolonging the study would be of any scientific value. In this case another 100 patients will be further included in the study. Enrollment time: The investigators will start the study as soon the local ethical committee will give us the permission. The investigators plan to start the study in July 2010. The end is expected for July 2012.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for phase_2 coronary-artery-disease

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2010

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

August 23, 2010

Completed
7 months until next milestone

First Posted

Study publicly available on registry

April 1, 2011

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2013

Completed
Last Updated

March 6, 2013

Status Verified

March 1, 2013

Enrollment Period

3.1 years

First QC Date

August 23, 2010

Last Update Submit

March 5, 2013

Conditions

Keywords

significant coronary artery diseasePCIradial approachwomenbifurcation lesionostial lesion7 Fr guiding catheterpercutaneous coronary intervention

Outcome Measures

Primary Outcomes (3)

  • Procedural success

    Procedural success, defined as a successful delivery of the stent using the sheathless guding catheter, in consecutive patients according to the inclusion criteria (women and bifurcation/ostial lesions) = technical feasibility of the sheathless catheter.

    baseline

  • Procedural safety

    Procedural safety, defined as the proportion of procedures performed in the absence of device-related complications (= safety of the sheathless catheter).

    baseline

  • Procedural safety

    Procedural safety, defined as the proportion of procedures performed in the absence of device-related complications (= safety of the sheathless catheter).

    +24 hours

Secondary Outcomes (2)

  • Safety and Tolerability

    baseline

  • safety and tolerability

    +24 hours

Study Arms (2)

Sheathless group

EXPERIMENTAL

patient randomized to the sheathless guiding catheter group

Procedure: trans-radial PCI (TRI)

Conventional group

ACTIVE COMPARATOR

patients randomized to the conventional guiding catheter group

Procedure: trans-radial PCI (TRI)

Interventions

TRI performed using the sheathless guiding approach

Sheathless group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients need to be at least 18 years old.
  • Patients presenting with a significant coronary artery disease who qualify for PCI and who can be treated by a radial approach.
  • Any women requiring PCI who can be treated by a radial approach.
  • Any patients with a bifurcation lesion or the ostial lesion of the left anterior descending (LAD) and/or left circumflex artery (LCX), lesions commonly treated with a 7 Fr guiding catheter.
  • Bifurcation lesion = any lesion of a main epicardial vessel (i.e. LAD, LCX, right coronary artery) involving at least one major side branch (i.e. diagonal or marginal branches).
  • Ostial lesion of the LAD or LCX = presence of a significant stenosis \<5mm from the distal part of the left main.

You may not qualify if:

  • Patients who refused to give their written informed consent.
  • Male patients, in whom PCI can be easily performed with a 6 Fr standard guiding catheter (i.e. no bifurcation or ostial lesion).
  • Patients in whom the radial approach is contra-indicated:
  • Patients with a dialysis arteria-venous fistula or in whom an arteria-venous fistula is planed in the future.
  • Patients with a known radial artery occlusion.
  • Patients in whom a radial approach was unsuccessfully already attempted in the past (anamnestic notion or previous medical record) secondary to a:
  • Challenging vessel anatomy,
  • Vessel tortuosity,
  • Known impossibility to cannulate the coronary ostia by the radial approach.
  • Patients in whom the Allen test results pathological bilaterally:
  • In case of pathological Allen test in one hand the other hand will be tested before choosing the femoral approach.
  • Patients in whom the femoral approach is adopted as primary catheterization approach (at interventionist's discretion), including:
  • Unstable patients (myocardial infarction, cardiogenic shock).
  • Patients necessitating femoral access for an intra-aortic balloon counterpulsation
  • Patients presenting with a double mammary coronary graft (right and left internal mammary utilized for by-pass grafts).
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University hospital

Geneva, Canton of Geneva, 1211, Switzerland

RECRUITING

Related Publications (2)

  • Mamas MA, Fath-Ordoubadi F, Fraser DG. Atraumatic complex transradial intervention using large bore sheathless guide catheter. Catheter Cardiovasc Interv. 2008 Sep 1;72(3):357-364. doi: 10.1002/ccd.21637.

    PMID: 18727126BACKGROUND
  • Mamas M, D'Souza S, Hendry C, Ali R, Iles-Smith H, Palmer K, El-Omar M, Fath-Ordoubadi F, Neyses L, Fraser DG. Use of the sheathless guide catheter during routine transradial percutaneous coronary intervention: a feasibility study. Catheter Cardiovasc Interv. 2010 Mar 1;75(4):596-602. doi: 10.1002/ccd.22246.

    PMID: 20049959BACKGROUND

Related Links

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

August 23, 2010

First Posted

April 1, 2011

Study Start

August 1, 2010

Primary Completion

September 1, 2013

Last Updated

March 6, 2013

Record last verified: 2013-03

Locations